Syncona Shs GBP (GB:SYNC) has released an update. Syncona Limited, a life science investment firm, has announced the purchase of 130,000 of its own ordinary shares at a volume-weighted average
Syncona Shs GBP (GB:SYNC) has released an update. Syncona Limited, a life science investment firm, has announced the purchase of 130,000 of its own ordinary shares at a volume-weighted average
Syncona Shs GBP (GB:SYNC) has released an update. Syncona Limited has announced a significant £63.5 million Series B investment in Resolution Therapeutics, a biopharmaceutical company focusing on macrophage therapy for
Syncona Shs GBP (GB:SYNC) has released an update. Syncona Limited, a prominent life science investor, has executed a share buyback programme as announced previously, purchasing 130,000 of its own ordinary
Syncona Shs GBP (GB:SYNC) has released an update. Syncona Limited, a prominent life science investor, has announced the purchase of 100,000 of its own shares at a price of 112.88
Syncona Shs GBP (GB:SYNC) has released an update. Syncona Limited, a firm dedicated to investing in life sciences, has announced their total voting rights as 639,065,994 based on the number